Current status of research on transcatheter arterial chemoembolization in treatment of colorectal cancer liver metastasis
10.3969/j.issn.1001-5256.2016.06.047
- VernacularTitle:经肝动脉化疗栓塞术治疗结直肠癌肝转移的研究进展
- Author:
Qianhong JIAN
1
;
Fangrong ZHENG
;
Xiong YAN
Author Information
1. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
- Publication Type:Research Article
- Keywords:
colorectal neoplasm;
neoplasm metastasis;
chemoembolization, therapeutic;
review
- From:
Journal of Clinical Hepatology
2016;32(6):1216-1219
- CountryChina
- Language:Chinese
-
Abstract:
It is widely acknowledged that the liver is the most common organ for colorectal cancer metastasis, and radical resection is thought to be the only therapeutic method to cure colorectal cancer liver metastasis (CRLM). Unfortunately, only about 20% of all patients are eligible for surgical resection. In patients who cannot be treated with surgery, transcatheter arterial chemoembolization (TACE) has been widely used as the preferred therapeutic method by scholars at home and abroad. This article introduces the application basis, indications, contraindications, therapeutic effect, chemotherapeutic agents, and embolic agents of TACE in the treatment of CRLM, and points out that TACE is a palliative treatment regimen with a clear therapeutic effect, minimal invasion, and few side effects and can be used as the preferred therapeutic regimen for patients with unresectable CRLM.
